88 related articles for article (PubMed ID: 28656288)
1. Vascular endothelial growth inhibitor 174 and its functional domains inhibit epithelial-mesenchymal transition in renal cell carcinoma cells in vitro.
Zhang N; Hong B; Lian W; Zhou C; Chen S; Du X; Deng X; Duoerkun S; Li Q; Yang Y; Gong K
Int J Mol Med; 2017 Aug; 40(2):569-575. PubMed ID: 28656288
[TBL] [Abstract][Full Text] [Related]
2. VEGI174 protein and its functional domain peptides exert antitumour effects on renal cell carcinoma.
Zhao Q; Hong B; Liu T; Ji Y; Tang X; Gong K; Ye L; Yang Y; Zhang N
Int J Oncol; 2019 Jan; 54(1):390-398. PubMed ID: 30431089
[TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Proteins Interacting with Vascular Endothelial Growth Inhibitor 174 in Renal Cell Carcinoma.
Zhao Q; Kun D; Hong B; Deng X; Guo S; Tang X; Yang Y; Gong K; Li Q; Ye L; Jiang WG; Zhang N
Anticancer Res; 2017 Aug; 37(8):4379-4388. PubMed ID: 28739731
[TBL] [Abstract][Full Text] [Related]
4. Protein of Vascular Endothelial Growth Inhibitor 174 Inhibits Epithelial-Mesenchymal Transition in Renal Cell Carcinoma
Zhao Q; Deng X; Hong B; Wang F; Tang X; Yang Y; Gong K; Ye L; Jiang WG; Zhang N
Anticancer Res; 2017 Aug; 37(8):4269-4275. PubMed ID: 28739718
[TBL] [Abstract][Full Text] [Related]
5. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
6. The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
Zhang N; Wu P; Wu L; Shayiremu D; Shan H; Ye L; Jiang WG; Gong K; Yang Y
Cancer Genomics Proteomics; 2013; 10(1):47-53. PubMed ID: 23382586
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
8. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
9. Vascular Endothelial Growth Inhibitor, a Cytokine of the Tumor Necrosis Factor Family, is Associated With Epithelial-Mesenchymal Transition in Renal Cell Carcinoma.
Zhao Q; Liu T; Hong B; Wang F; Zhou C; Du X; Chen S; Deng X; Duoerkun S; Li Q; Yang Y; Gong K; Zhang N
Appl Immunohistochem Mol Morphol; 2018; 26(10):727-733. PubMed ID: 28362712
[TBL] [Abstract][Full Text] [Related]
10. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
11. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
[TBL] [Abstract][Full Text] [Related]
13. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
14. Parthenolide inhibits the tumor characteristics of renal cell carcinoma.
Liu D; Han Y; Liu L; Ren X; Zhang H; Fan S; Qin T; Li L
Int J Oncol; 2021 Jan; 58(1):100-110. PubMed ID: 33367934
[TBL] [Abstract][Full Text] [Related]
15. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG.
Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q
Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
[TBL] [Abstract][Full Text] [Related]
17. Cobalt Chloride-induced Hypoxia Induces Epithelial-mesenchymal Transition in Renal Carcinoma Cell Lines.
Zhang N; Hong B; Zhou C; Du X; Chen S; Deng X; Duoerkun S; Li Q; Yang Y; Gong K
Ann Clin Lab Sci; 2017 Jan; 47(1):40-46. PubMed ID: 28249915
[TBL] [Abstract][Full Text] [Related]
18. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
[TBL] [Abstract][Full Text] [Related]
19. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
[TBL] [Abstract][Full Text] [Related]
20. The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma.
O'Mahony FC; Faratian D; Varley J; Nanda J; Theodoulou M; Riddick AC; Harrison DJ; Stewart GD
PLoS One; 2012; 7(2):e31557. PubMed ID: 22363672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
